According to Mingchen Health's announcement, the first three quarters of 2026 achieved operating income of 1,375 billion yuan, a year-on-year increase of 27.48%; net loss attributable to shareholders of listed companies was 35.6.004 million yuan, a year-on-year decrease of 183.67%; net loss after deducting non-recurring profit and loss was 36.4833 million yuan, a year-on-year decrease of 188.51%. The third quarter of 2026 achieved operating income of 479 million yuan, a year-on-year increase of 30.54%; net loss attributable to shareholders of listed companies was 305.325 million yuan, a year-on-year decrease of 2153.02%. Furthermore, Kashi Arcane's performance promise fell short, and the compensator should pay 104 million yuan in compensation. As of the date the report was disclosed, 25 million yuan had been received.

According to Mingchen Health's announcement, the first three quarters of 2026 achieved operating income of 1,375 billion yuan, a year-on-year increase of 27.48%; net loss attributable to shareholders of listed companies was 35.6.004 million yuan, a year-on-year decrease of 183.67%; net loss after deducting non-recurring profit and loss was 36.4833 million yuan, a year-on-year decrease of 188.51%. The third quarter of 2026 achieved operating income of 479 million yuan, a year-on-year increase of 30.54%; net loss attributable to shareholders of listed companies was 305.325 million yuan, a year-on-year decrease of 2153.02%. Furthermore, Kashi Arcane's performance promise fell short, and the compensator should pay 104 million yuan in compensation. As of the date the report was disclosed, 25 million yuan had been received.